Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial

被引：0

作者：

Chloé Laurencin

Noémie Timestit

Ana Marques

Domitille Dilly Duchez

Caroline Giordana

Sara Meoni

Marine Huddlestone

Teodor Danaila

Mathieu Anheim

Hélène Klinger

Tiphaine Vidal

Marion Fatisson

Catherine Caire

Mikail Nourredine

Philippe Boulinguez

Carole Dhelens

Bénédicte Ballanger

Stéphane Prange

Sylvie Bin

Stéphane Thobois

机构：

[1] Pierre Wertheimer Neurological Hospital,Department of Neurology C, Expert Parkinson Centre, Hospices Civils de Lyon

[2] Hôpital Neurologique Pierre Wertheimer,Lyon Neuroscience Research Centre

[3] INSERM,Department of Biostatistics

[4] University of Lyon,Department of Neurology

[5] University Hospital of Lyon,Department of Neurology

[6] Clermont-Ferrand University Hospital,Department of Neurology

[7] University Hospital of Saint-Etienne,Movement Disorders Unit, Department of Neurology

[8] University Hospital of Nice,Department of Neurology

[9] University Hospital of Grenoble,Pharmacotoxicology Laboratory, Department of Clinical Research and Epidemiology

[10] Strasbourg University Hospital,Pharmacy, FRIPHARM

[11] University Hospital of Lyon,Public Health Center, Research and Clinical Epidemiology

[12] Edouard Herriot Hospital,Faculté de Medecine Et de Maieutique Lyon Sud Charles Mérieux

[13] Lyon University Hospital,Institut de Génétique Et de Biologie Moléculaire Et Cellulaire (IGBMC)

[14] University Hospital of Lyon,Centre de Référence Des Maladies Neurogénétiques Rares, Fédération de Médecine Translationnelle de Strasbourg (FMTS)

[15] Marc Jeannerod Cognitive Neuroscience Institute,undefined

[16] Université Claude Bernard Lyon 1,undefined

[17] Université de Lyon,undefined

[18] INSERM-U964/CNRS,undefined

[19] UMR7104/Strasbourg University,undefined

[20] Université de Strasbourg,undefined

来源：

Journal of Neurology | 2023年 / 270卷

关键词：

Clonidine; Noradrenergic system; Parkinson’s disease; Impulse control disorder; QUIP-RS;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：4851 / 4859

页数：8

共 50 条

[31] EFFICACY AND SAFETY OF ESMOLOL VS PROPRANOLOL IN THE TREATMENT OF SUPRAVENTRICULAR TACHYARRHYTHMIAS - A MULTICENTER DOUBLE-BLIND CLINICAL-TRIAL
ABRAMS, J
ALLEN, J
ALLIN, D
ANDERSON, J
ANDERSON, S
BLANSKI, L
CHADDA, K
DIBIANCO, R
FAVROT, L
GONZALEZ, J
HOROWITZ, L
LADDU, A
LEE, R
MACCOSBE, P
MORGANROTH, J
NARULA, O
SINGH, B
SINGH, J
STECK, J
SWERDLOW, C
TURLAPATY, P
WALDO, A
AMERICAN HEART JOURNAL, 1985, 110 (05) : 913 - 922
[32] Mexazolam and alprazolam in the treatment of generalised anxiety disorder - A double-blind, randomised clinical trial
Vaz-Serra, A
Figueira, ML
Bessa-Peixoto, A
Firmino, H
Albuquerque, R
Paz, C
Dolgner, A
Vaz-Silva, M
Almeida, L
CLINICAL DRUG INVESTIGATION, 2001, 21 (04) : 257 - 263
[33] Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo- controlled, phase 4 clinical trial
Borup, Christian
Vinter-Jensen, Lars
Jorgensen, Soren Peter German
Wildt, Signe
Graff, Jesper
Gregersen, Tine
Zaremba, Anna
Andersen, Trine Borup
Nojgaard, Camilla
Timm, Hans Bording
Rainteau, Dominique
Hansen, Svend Hoime
Rumessen, Juri Johannes
Munck, Lars Kristian
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (04): : 321 - 331
[34] A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
Lafayette, Richard
Barbour, Sean
Israni, Rubeen
Wei, Xuelian
Eren, Necmi
Floege, Juergen
Jha, Vivekanand
Kim, Sung Gyun
Maes, Bart
Phoon, Richard K. S.
Singh, Harmeet
Tesar, Vladimir
Lin, Celia J. F.
Barratt, Jonathan
KIDNEY INTERNATIONAL, 2024, 105 (06) : 1306 - 1315
[35] Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
Poewe, Werner H.
Rascol, Olivier
Quinn, Niall
Tolosa, Eduardo
Oertel, Wolfgang H.
Martignoni, Emilia
Rupp, Markus
Boroojerdi, Babak
LANCET NEUROLOGY, 2007, 6 (06): : 513 - 520
[36] Efficacy and Safety of On Demand Clomipramine for the Treatment of Premature Ejaculation: A Multicenter, Randomized, Double-Blind, Phase III Clinical Trial EDITORIAL COMMENT
Shindel, Alan W.
JOURNAL OF UROLOGY, 2019, 201 (01): : 152 - 153
[37] Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Zajecka, John
Schatzberg, Alan
Stahl, Stephen
Shah, Amy
Caputo, Angelika
Post, Anke
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 135 - 144
[38] Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Mcgarry, Andrew
Rosanbalm, Shane
Leinonen, Mika
Olanow, Warren
To, Dennis
Bell, Adam
Lee, Daniel
Chang, Jamie
Dubow, Jordan
Dhall, Rohit
Burdick, Daniel
Parashos, Sotirios
Feuerstein, Jeanne
Quinn, Joseph
Pahwa, Rajesh
Afshari, Mitra
Ramirez-Zamora, Aldolfo
Chou, Kelvin
Tarakad, Arjun
Luca, Corneliu
Klos, Kevin
Bordelon, Yvette
St Hiliare, Marie-Helene
Shprecher, David
Lee, Seulki
Dawson, Ted M.
Roschke, Viktor
Kieburtz, Karl
LANCET NEUROLOGY, 2024, 23 (01): : 37 - 45
[39] Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial
Taylor, Lyndsay
Ahmada, Ahmada Ali
Ali, Msanif Said
Ali, Said Mohammed
Hattendorf, Jan
Mohammed, Ibrahim Said
Keiser, Jennifer
LANCET, 2024, 404 (10453): : 683 - 691
[40] Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
Soileau, Michael J.
Aldred, Jason
Budur, Kumar
Fisseha, Nahome
Fung, Victor Sc
Jeong, Anna
Kimber, Thomas E.
Klos, Kevin
Litvan, Irene
O'Neill, Daniel
Robieson, Weining Z.
Spindler, Meredith A.
Standaert, David G.
Talapala, Saritha
Vaou, Eleni Okeanis
Zheng, Hui
Facheris, Maurizio F.
Hauser, Robert A.
LANCET NEUROLOGY, 2022, 21 (12): : 1099 - 1109

← 1 2 3 4 5 →